{
    "paper_id": "PMC7231517",
    "metadata": {
        "title": "Intravenous Anakinra for Macrophage Activation Syndrome May Hold Lessons for Treatment of Cytokine Storm in the Setting of Coronavirus Disease 2019",
        "authors": [
            {
                "first": "Theresa",
                "middle": [
                    "L."
                ],
                "last": "Wampler Muskardin",
                "suffix": "",
                "email": "theresa.wamplermuskardin@nyulangone.org",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Dr. Wampler Muskardin drafted the article, revised it critically for important intellectual content, and approved the final version to be published.",
            "cite_spans": [],
            "section": "Author Contributions",
            "ref_spans": []
        }
    ],
    "ref_entries": {},
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation",
            "authors": [],
            "year": 2009,
            "venue": "Pediatr Crit Care Med",
            "volume": "10",
            "issn": "",
            "pages": "387-92",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "Macrophage activation syndrome and cytokine\u2010directed therapies",
            "authors": [],
            "year": 2014,
            "venue": "Best Pract Res Clin Rheumatol",
            "volume": "28",
            "issn": "",
            "pages": "277-92",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "HLH\u20102004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis",
            "authors": [],
            "year": 2007,
            "venue": "Pediatr Blood Cancer",
            "volume": "48",
            "issn": "",
            "pages": "124-31",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation collaborative initiative",
            "authors": [],
            "year": 2016,
            "venue": "Arthritis Rheumatol",
            "volume": "68",
            "issn": "",
            "pages": "566-76",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "Recommendations for the management of hemophagocytic lymphohistiocytosis in adults",
            "authors": [],
            "year": 2019,
            "venue": "Blood",
            "volume": "133",
            "issn": "",
            "pages": "2465-77",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "How I treat hemophagocytic lymphohistiocytosis",
            "authors": [],
            "year": 2011,
            "venue": "Blood",
            "volume": "118",
            "issn": "",
            "pages": "4041-52",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "HLH\u201094: a treatment protocol for hemophagocytic lymphohistiocytosis",
            "authors": [],
            "year": 1997,
            "venue": "Med Pediatr Oncol",
            "volume": "28",
            "issn": "",
            "pages": "342-7",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis",
            "authors": [],
            "year": 2019,
            "venue": "J Intensive Care Med",
            "volume": "34",
            "issn": "",
            "pages": "723-31",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome",
            "authors": [],
            "year": 2019,
            "venue": "Pediatr Rheumatol Online J",
            "volume": "17",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Therapeutic role of anakinra, an interleukin\u20101 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children",
            "authors": [],
            "year": 2014,
            "venue": "Pediatr Crit Care Med",
            "volume": "15",
            "issn": "",
            "pages": "401-8",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "A personalized diagnostic and treatment approach for macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in adults",
            "authors": [],
            "year": 2017,
            "venue": "J Clin Immunol",
            "volume": "37",
            "issn": "",
            "pages": "638-43",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "Continuous intravenous anakinra infusion to calm the cytokine storm in macrophage activation syndrome",
            "authors": [],
            "year": 2020,
            "venue": "ACR Open Rheumatol",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "Long\u2010term safety profile of anakinra in patients with severe cryopyrin\u2010associated periodic syndromes",
            "authors": [],
            "year": 2016,
            "venue": "Rheumatology (Oxford)",
            "volume": "55",
            "issn": "",
            "pages": "1499-506",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "Confirmatory interleukin\u20101 receptor antagonist trial in severe sepsis: a phase III, randomized, double\u2010blind, placebo\u2010controlled, multicenter trial",
            "authors": [],
            "year": 1997,
            "venue": "Crit Care Med",
            "volume": "25",
            "issn": "",
            "pages": "1115-24",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "Anakinra pharmacokinetics in children and adolescents with systemic\u2010onset juvenile idiopathic arthritis and autoinflammatory syndromes",
            "authors": [],
            "year": 2013,
            "venue": "BMC Pharmacol Toxicol",
            "volume": "14",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "Interleukin\u20101 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial",
            "authors": [],
            "year": 2016,
            "venue": "Crit Care Med",
            "volume": "44",
            "issn": "",
            "pages": "275-81",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "Adults with septic shock and extreme hyperferritinemia exhibit pathogenic immune variation",
            "authors": [],
            "year": 2019,
            "venue": "Genes Immun",
            "volume": "20",
            "issn": "",
            "pages": "520-6",
            "other_ids": {
                "DOI": []
            }
        }
    }
}